$46.27 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Join the waitlist

About PPD Inc

PPD, Inc. provides drug development services to the biopharmaceutical industry. The Company provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The Company’s business segments include Clinical Development Services segment and Laboratory Services segment. Its Clinical Development Services offerings span the lifecycle of clinical product development and includes product development and consulting services, early development services, phases II-IV clinical trial management, accelerated enrollment solutions, peri- and post-approval services and medical communications. The Company’s Laboratory Services segment offers bioanalytical laboratory services, biomarker laboratory services, vaccine science services, good manufacturing practice (GMP) laboratory services and central laboratory services.

Stock Analysis

last close $46.27
1-mo return 23.7%
3-mo return 26.8%
avg daily vol. 5.18M
52-week high 46.46
52-week low 21.46
market cap. $13.4B
forward pe 32.7
annual div. -
roe -
ltg forecast 16.9%
dividend yield -
annual rev. $4.4B
inst own. 77.3%

Join the waitlist for early access and a chance to earn $50 in free stock

Join the waitlist